Skip to main content
Top

Dermatology and Therapy

Issue 11/2022

Content (14 Articles)

Open Access Care Review

Unmet Need in People with Psoriasis and Skin of Color in Canada and the United States

Geeta Yadav, Jensen Yeung, Yvette Miller-Monthrope, Omair Lakhani, Christopher Drudge, Samantha Craigie, Ari Mendell, Laura Park-Wyllie

Open Access Nevi Review

Body Site Distribution of Acquired Melanocytic Naevi and Associated Characteristics in the General Population of Caucasian Adults: A Scoping Review

Dilki Jayasinghe, Kaitlin L. Nufer, Brigid Betz-Stablein, H. Peter Soyer, Monika Janda

Open Access Atopic Dermatitis Original Research

Tralokinumab Efficacy and Safety, with or without Topical Corticosteroids, in North American Adults with Moderate-to-Severe Atopic Dermatitis: A Subanalysis of Phase 3 Trials ECZTRA 1, 2, and 3

Andrew Blauvelt, Melinda Gooderham, Neal Bhatia, Richard G. Langley, Shannon Schneider, John Zoidis, Azra Kurbasic, April Armstrong, Jonathan I. Silverberg

Open Access Lymphoma Original Research

Chlormethine Gel for the Treatment of Mycosis Fungoides Cutaneous T-Cell Lymphoma: In Vitro Release and Permeation Testing

Claudio Giuliano, Stefano Frizzarin, Alessandro Alonzi, Virginia Stimamiglio, Pablo L. Ortiz-Romero

Open Access Erythema Original Research

Evaluation of a Sunscreen Product Compared with Reference Standards P3, P5 and P8 in Outdoor Conditions: a Randomized, Double-Blinded, Intra-individual Study in Healthy Subjects

Corinne Granger, Gitanjali Petkar, Muzzammil Hosenally, Javier Bustos, Carles Trullàs, Thierry Passeron, Jean Krutmann

Open Access Atopic Dermatitis Original Research

Patient Characteristics, Treatment Patterns, Healthcare Resource Utilization, and Costs of Targeted Therapy-Eligible Atopic Dermatitis Patients in Taiwan—A Real-World Study

Chao-Hsiun Tang, Yao-Hsien Huang, Po-Ya Chuang, Bruce C. M. Wang, Ching-Yun Wei, Khai Jing Ng, Tamas Treuer, Chia-Yu Chu

Open Access Original Research

Efficacy and Safety of Monopolar Radiofrequency for Treatment of Lower Facial Laxity in Asians

Rungsima Wanitphakdeedecha, Yuri Yogya, Chadakan Yan, Phumithep Phumariyapong, Yanisorn Nanchaipruek, Panwadee Thongjaroensirikul, Pitchaya Maneeprasopchoke, Thanya Techapichetvanich, Sasima Eimpunth, Woraphong Manuskiatti

Open Access Lipoma Original Research

A Scoring System That Predicts Difficult Lipoma Resection: Logistic Regression and Tenfold Cross-Validation Analysis

Goh Akiyama, Shimpei Ono, Tetsuro Sekine, Satoshi Usami, Rei Ogawa

Open Access Atopic Dermatitis Brief Report

Clinical Efficacy of a Digital Intervention for Patients with Atopic Dermatitis: a Prospective Single-Center Study

Sigrídur Lára Gudmundsdóttir, Tommaso Ballarini, María L. Ámundadóttir, Judit Mészáros, Jenna H. Eysteinsdóttir, Ragna H. Thorleifsdóttir, Sigrídur K. Hrafnkelsdóttir, Heida B. Bragadóttir, Saemundur Oddsson, Jonathan I. Silverberg

Open Access Vulgar Psoriasis Brief Report

Secukinumab in Patients with Psoriasis and a Personal History of Malignancy: A Multicenter Real-Life Observational Study

Cristina Pellegrini, Maria Esposito, Ernesto Rossi, Paolo Gisondi, Stefano Piaserico, Paolo Dapavo, Andrea Conti, Alessio Gambardella, Martina Burlando, Alessandra Narcisi, Annamaria Offidani, Riccardo Balestri, Federico Bardazzi, Francesca Prignano, Cristina Mugheddu, Marco Romanelli, Giovanna Malara, Giovanni Schinzari, Maria Concetta Fargnoli

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine